Rchr
J-GLOBAL ID:201801007300027647   Update date: Nov. 12, 2024

Tabu Kouichi

タブ コウイチ | Tabu Kouichi
Affiliation and department:
Job title: Assistant Professor
Homepage URL  (2): http://www.tmd.ac.jp/mri/scr/index.htmlhttp://www.tmd.ac.jp/mri/scr/english/index.html
Research field  (7): Tumor biology ,  Polymer chemistry ,  Tumor diagnostics and therapeutics ,  Chemical biology ,  Immunology ,  Neurosurgery ,  Biomaterials
Research keywords  (6): がん幹細胞 ,  微小環境 ,  ケミカルバイオロジー ,  ポリマー化学 ,  グリオーマ ,  免疫
Research theme for competitive and other funds  (13):
  • 2024 - 2027 Establishment of new therapeutic strategies based on the mechanisms underlying CSC-mediated niche reconstruction
  • 2022 - 2025 グリオーマ根治を実現する放射線駆動型ポリマーマルチターゲット薬の開発
  • 2020 - 2023 人工微小環境アレイを用いた新規フェノミクスの創出とがん幹細胞層別化療法の開発
  • 2019 - 2022 がん幹細胞制御性高分子ハイドロゲルによる新しいがん治療戦略の開発
  • 2019 - 2021 がん幹細胞機能性ポリマーによるグリオーマの新規治療標的探索
Show all
Papers (31):
  • Tanakorn Tarapongpun, Nattawat Onlamoon, Kouichi Tabu, Suebwong Chuthapisith, Tetsuya Taga. FGF-2 enhances preadipocyte lineage commitment in human adipose-derived mesenchymal stem cells. Genes Cells. 2024
  • Yoshitaka Murota, Mariko Nagane, Mei Wu, Mithun Santra, Seshasailam Venkateswaran, Shinji Tanaka, Mark Bradley, Tetsuya Taga, Kouichi Tabu. A niche-mimicking polymer hydrogel-based approach to identify molecular targets for tackling human pancreatic cancer stem cells. Inflammation and Regeneration. 2023
  • Kouichi Tabu, Tetsuya Taga. Cancer ego-system in glioma: an iron-replenishing niche network systemically self-organized by cancer stem cells. Inflammation and Regeneration. 2022. 42. 1. 54
  • Wenqian Wang, Kouichi Tabu, Alapati Aimaitijiang, Tetsuya Taga. Therapy-resistant nature of cancer stem cells in view of iron metabolism. Inflammation and Regeneration. 2022. 42. 1. 34
  • Yoshitaka Murota, Kouichi Tabu, Tetsuya Taga. Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas. Cells. 2022. 11. 13. 2054-2054
more...
MISC (9):
more...
Lectures and oral presentations  (79):
  • C3a receptor-mediated self-sacrificing adaptation in cancer stem cells contributing to glioma recurrence
    (2024)
  • 補体フラグメント受容体C3aR1を標的とするグリオーマ再発制御機構の解明
    (第45回日本炎症・再生医学会 2024)
  • Identification of a niche-mimicking synthetic polymer scaffold for the maintenance of neural stem cells in a culture system without growth factors and serum
    (2024)
  • Combinatorial Use of EGF and FGFs to Prime Human Adipose-derived Mesenchymal Stem Cells for Pre-adipocyte Commitment
    (2023)
  • Differential susceptibility of mouse adult neural stem cells and astrocytes to oncogenic transformation
    (The 82nd Annual Meeting of the Japanese Cancer Association 2023)
more...
Education (2):
  • 2004 - 2007 Hokkaido University Graduate School, Division of Medicine
  • 1998 - 2004 Hokkaido University Faculty of Veterinary Medicine
Professional career (1):
  • 医学博士 (北海道大学)
Work history (7):
  • 2021/04 - 現在 Tokyo Medical and Dental University
  • 2014/09 - 2021/03 Tokyo Medical and Dental University Medical Research Institute Assistant Professor
  • 2020/02 - 2020/03 School of Chemistry The University of Edinburgh Visiting Assistant Professor
  • 2012/04 - 2014/08 Tokyo Medical and Dental University Medical Research Institute Project Assistant Professor
  • 2009/04 - 2012/03 Tokyo Medical and Dental University Medical Research Institute JSPS Research Fellow
Show all
Committee career (2):
  • 2022/04 - 現在 The Japanese Society of Inflammation and Regeneration 評議員
  • 2022/04 - 現在 The Japanese Society of Inflammation and Regeneration 次世代リーダー育成委員会
Awards (7):
  • 2024 - 第45回日本炎症・再生医学会 ポスター発表優秀演題
  • 2022 - 第43回日本炎症・再生医学会 ポスター発表優秀演題
  • 2017 - 2016年度 東京医科歯科大学難治疾患研究所 優秀論文賞
  • 2012 - 2011年度 東京医科歯科大学難治疾患研究所 若手研究者発表会優秀賞
  • 2011 - 文部科学省科学研究費新学術領域研究「がん研究分野の特性等を踏まえた支援活動」 2011年度 がん若手研究者ワークショップ ベストポスター賞
Show all
Association Membership(s) (3):
日本炎症・再生医学会 ,  THE JAPANESE CANCER ASSOCIATION ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page